| Jahnavi Chakrala, MD | |
|
20229 E 9 Mile Rd Ste 200, Saint Clair Shores, MI 48080-1775 | |
| (586) 267-0200 | |
| (313) 343-4412 |
| Full Name | Jahnavi Chakrala |
|---|---|
| Gender | Female |
| Speciality | Endocrinology |
| Experience | 18 Years |
| Location | 20229 E 9 Mile Rd Ste 200, Saint Clair Shores, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003237934 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 4301502783 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension St John Hospital | Detroit, MI | Hospital |
| Beaumont Hospital, Troy | Troy, MI | Hospital |
| Ascension Macomb Oakland Hosp-warren Campus | Warren, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ascension Michigan-cmg | 7517162761 | 64 |
News Archive
The authors state that there are serious infectious, as well as non-infectious risks associated with blood transfusions and that it should now be viewed as a legal requirement for patients to be informed about specific risks posed by blood transfusions. This would work in the same way as they are currently informed about risks associated with the medical treatment and/or surgery they undergo.
Greater use of erythropoiesis-stimulating agents (ESAs) and more frequent use of iron at lower hematocrit levels (the proportion of the blood that consists of red blood cells) was associated with a decreased risk of death for hemodialysis patients, according to a study in the March 3 issue of JAMA.
Leipzig: The long-term effects of pesticides on living organisms in rivers and on water quality can now be assessed more easily. Researchers from the Helmholtz Centre for Environmental Research (UFZ) have developed a tool that can estimate the harmful effect of pesticides, such as those flushed into rivers and streams from agricultural land, within minutes.
Aeterna Zentaris Inc., today announced that an interim review of a Phase 3 trial of AEZS-130 (macimorelin, SolorelTM), demonstrates the compound may provide a simple, well-tolerated and safe oral diagnostic test for Adult Growth Hormone Deficiency (AGHD). The data was presented earlier today by Beverly M.K. Biller, M.D. of the Harvard Medical School/Massachusetts General Hospital in Boston, at the 5th International Congress of the Growth Hormone Research Society (GRS) and the Insulin-like Growth Factors (IGF) Society in New York City.
› Verified 2 days ago
| Entity Name | Ascension Michigan-cmg |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851765374 PECOS PAC ID: 7517162761 Enrollment ID: O20160127001523 |
News Archive
The authors state that there are serious infectious, as well as non-infectious risks associated with blood transfusions and that it should now be viewed as a legal requirement for patients to be informed about specific risks posed by blood transfusions. This would work in the same way as they are currently informed about risks associated with the medical treatment and/or surgery they undergo.
Greater use of erythropoiesis-stimulating agents (ESAs) and more frequent use of iron at lower hematocrit levels (the proportion of the blood that consists of red blood cells) was associated with a decreased risk of death for hemodialysis patients, according to a study in the March 3 issue of JAMA.
Leipzig: The long-term effects of pesticides on living organisms in rivers and on water quality can now be assessed more easily. Researchers from the Helmholtz Centre for Environmental Research (UFZ) have developed a tool that can estimate the harmful effect of pesticides, such as those flushed into rivers and streams from agricultural land, within minutes.
Aeterna Zentaris Inc., today announced that an interim review of a Phase 3 trial of AEZS-130 (macimorelin, SolorelTM), demonstrates the compound may provide a simple, well-tolerated and safe oral diagnostic test for Adult Growth Hormone Deficiency (AGHD). The data was presented earlier today by Beverly M.K. Biller, M.D. of the Harvard Medical School/Massachusetts General Hospital in Boston, at the 5th International Congress of the Growth Hormone Research Society (GRS) and the Insulin-like Growth Factors (IGF) Society in New York City.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jahnavi Chakrala, MD 20229 E 9 Mile Rd Ste 200, Saint Clair Shores, MI 48080-1775 Ph: (586) 267-0200 | Jahnavi Chakrala, MD 20229 E 9 Mile Rd Ste 200, Saint Clair Shores, MI 48080-1775 Ph: (586) 267-0200 |
News Archive
The authors state that there are serious infectious, as well as non-infectious risks associated with blood transfusions and that it should now be viewed as a legal requirement for patients to be informed about specific risks posed by blood transfusions. This would work in the same way as they are currently informed about risks associated with the medical treatment and/or surgery they undergo.
Greater use of erythropoiesis-stimulating agents (ESAs) and more frequent use of iron at lower hematocrit levels (the proportion of the blood that consists of red blood cells) was associated with a decreased risk of death for hemodialysis patients, according to a study in the March 3 issue of JAMA.
Leipzig: The long-term effects of pesticides on living organisms in rivers and on water quality can now be assessed more easily. Researchers from the Helmholtz Centre for Environmental Research (UFZ) have developed a tool that can estimate the harmful effect of pesticides, such as those flushed into rivers and streams from agricultural land, within minutes.
Aeterna Zentaris Inc., today announced that an interim review of a Phase 3 trial of AEZS-130 (macimorelin, SolorelTM), demonstrates the compound may provide a simple, well-tolerated and safe oral diagnostic test for Adult Growth Hormone Deficiency (AGHD). The data was presented earlier today by Beverly M.K. Biller, M.D. of the Harvard Medical School/Massachusetts General Hospital in Boston, at the 5th International Congress of the Growth Hormone Research Society (GRS) and the Insulin-like Growth Factors (IGF) Society in New York City.
› Verified 2 days ago
Kimberley Demerle, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 21000 E 12 Mile Rd Ste 112, Saint Clair Shores, MI 48081 Phone: 586-772-5550 Fax: 586-772-2470 | |
Maridel Aileen Hernandez, DO Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 19603 E 8 Mile Rd, Saint Clair Shores, MI 48080 Phone: 586-445-7900 Fax: 586-445-7940 | |
Daniel Shelden, DO Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 23715 Little Mack Ave Ste 100, Saint Clair Shores, MI 48080 Phone: 586-447-8021 Fax: 586-447-8022 | |
Dr. Demetrios Mermiges, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 19611 E 8 Mile Rd, Saint Clair Shores, MI 48080 Phone: 586-772-6850 Fax: 586-772-3810 | |
Zaid Kasmikha, D.O. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 24211 Little Mack Ave, Saint Clair Shores, MI 48080 Phone: 586-498-0440 Fax: 586-498-0429 | |
Dr. Marybeth Hardwicke, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 23411 Jefferson Ave, Suite 100, Saint Clair Shores, MI 48080 Phone: 586-778-4080 Fax: 586-778-6055 |